+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Search Bar & Filters

Found 3 Actively Recruiting clinical trials

R

Actively Recruiting

Healthy Volunteer

This research aims to help families in Cambodia switch from traditional wood or charcoal stoves to electric induction stoves, studying whether this change is safe, affordable, and sustainable. It focuses on reducing household air pollution, which is linked to serious health problems, and evaluates which strategies best encourage families to use induction stoves regularly while stopping traditional cooking methods. The study compares different approaches in 65 peri-urban villages, including community engagement, direct sales, financial subsidies, and combinations of these. Participants receive an electric induction stove with two burners and compatible cookware, accompanied by cloud-connected devices that track stove use. Some villages serve as controls and do not receive interventions during the trial. Participants will have their stove use monitored with special devices and air pollution measured in their homes before and after receiving induction stoves. Researchers will also collect information on cooking habits and experiences through surveys and interviews. The main outcomes measured are the proportion of households purchasing induction stoves and the number of meals cooked without biomass fuels, assessed 18 to 30 months post-intervention. The study includes ongoing evaluation of stove use patterns and household air pollution exposure over time.

Age: 18Years +All GendersPhase Not Applicable
1 location
U

Actively Recruiting

Healthy Volunteer

Vector-borne diseases, caused by bites from infected insects like mosquitoes and ticks, are a major health concern worldwide, causing nearly 1 million deaths annually. These illnesses are increasing, especially in Southeast Asia, with about 10 percent of fevers in Cambodia linked to such infections. Many cases go undiagnosed due to limited diagnostic resources, so researchers aim to better understand these diseases and identify infectious causes of unexplained fevers using advanced genetic sequencing methods. Participants include individuals aged at least 2 months who have a fever of 38 degrees Celsius or higher, or who are diagnosed with certain high-risk pathogens. Close contacts of infected individuals may also join the study. Participants provide information about their health, travel history, and demographics. Blood samples and nasal swabs if respiratory symptoms are present are collected for testing. Optional follow-up samples may be collected within 1 to 2 weeks andor up to 3 months after enrollment. During the study, participants answer health questionnaires and undergo blood and nasal testing to detect pathogens and immune responses. Researchers analyze pathogen genetic sequences and assess reactions to insect saliva proteins. The study includes initial enrollment and optional follow-up visits to track infections and immune changes over time. Total participation duration varies depending on follow-up involvement.

Age: 2Months +All Genders
6 locations
E

Actively Recruiting

Healthy Volunteer

Researchers are investigating immune responses in serious dengue disease by comparing blood samples from people hospitalized with dengue-like illness, influenza, sepsis, and healthy controls. The study aims to better understand how the immune system changes over time during dengue infection and to identify potential targets for new treatments. The study includes about 200 dengue-like illness patients, 50 with influenza, 30 with sepsis, and up to 50 healthy participants. Participants with dengue and sepsis will have blood collected at enrollment, day 1, and day 3, while dengue patients have an additional blood draw on day 21. Influenza patients will have a nasopharyngeal swab and blood taken at enrollment, with blood draws also on days 3 and 21. Healthy controls will provide a single blood sample at enrollment. This design allows detailed analysis of immune changes including neutrophils, cytokines, and adaptive immune responses. During the study, participants will provide clinical data and blood samples at specified time points. Researchers will measure immune markers such as neutrophil characteristics and cytokine levels from enrollment up to day 21 for dengue patients. The study tracks immune responses over time and compares them across groups to understand disease progression. Participation lasts up to 21 days depending on group, with close monitoring of immune activity and clinical status.

Age: 2Years +All Genders
4 locations